NEOG - NEOGEN CORP
9.42
-0.210 -2.229%
Share volume: 2,546,597
Last Updated: 04-21-2026
Pharmaceutical Products/In Vitro, In Vivo Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$9.63
-0.21
-0.02%
View ratios
| Fiscal Date | 05-31-2024 | 08-31-2024 | 11-30-2024 | 02-28-2025 | 05-31-2025 | 08-31-2025 | 11-30-2025 | 02-28-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q1 2024 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
| Report Date | 01-15-2025 | 10-10-2024 | 01-15-2025 | 04-09-2025 | 07-30-2025 | 10-09-2025 | 01-08-2026 | 04-09-2026 | |
| Total revenue | 236.794 M | 216.964 M | 231.258 M | 220.980 M | 0.000 | 209.189 M | 224.691 M | 211.200 M | |
| Cost of revenue | 123.312 M | 112.038 M | 117.928 M | 110.715 M | 0.000 | 114.219 M | 118.007 M | 112.200 M | |
| Gross profit | 113.482 M | 104.926 M | 113.330 M | 110.265 M | 0.000 | 94.970 M | 106.684 M | 99.000 M | |
| -7.54% | 8.01% | -2.70% | -100.00% | 12.33% | -7.20% | ||||
| Operating expenses | 56.105 M | 56.870 M | 62.879 M | 60.255 M | 0.000 | 66.013 M | 69.771 M | 64.100 M | |
| Selling general and admin | 50.960 M | 51.671 M | 57.771 M | 55.782 M | 0.000 | 60.888 M | 65.208 M | 60.300 M | |
| Research and development | 5.145 M | 5.199 M | 5.108 M | 4.473 M | 0.000 | 5.125 M | 4.563 M | 3.800 M | |
| Total expenses | 100.442 M | 102.669 M | 570.814 M | 104.850 M | 0.000 | 111.061 M | 112.061 M | 102.300 M | |
| 2.22% | 455.98% | -81.63% | -100.00% | 0.90% | -8.71% | ||||
| Operating income | 13.040 M | 2.257 M | -457.484 M | 5.415 M | 0.000 | -16.091 M | -5.377 M | -3.300 M | |
| Ebit | 11.125 M | 0.000 | -459.205 M | 7.311 M | 0.000 | 59.332 M | -6.108 M | -6.400 M | |
| Pretax income | -6.399 M | -15.609 M | -476.572 M | -9.727 M | 0.000 | 43.808 M | -20.364 M | -20.300 M | |
| 143.93% | 2,953.19% | -97.96% | -100.00% | -146.48% | -0.31% | ||||
| Income tax | -984.000 K | -3.000 M | -20.290 M | 1.230 M | 0.000 | 7.470 M | -4.440 M | -3.300 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -5.415 M | -12.609 M | -456.282 M | -10.957 M | 0.000 | 36.338 M | -15.924 M | -17.000 M | |
| -132.85% | -3,518.70% | 97.60% | 100.00% | -143.82% | -6.76% |